Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC.SI · Entity 5607 | Director | June 26, 2026 | June 29, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SHOULDER INNOVATIONS, INC.
Report date June 26, 2026 · Filed June 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 18,712 |
Reported balance
After 2026-06-26 transaction · row 1
1 source rowRow 1 · 2026-06-26 · Grant · Acquired 5,046 · Balance 18,712 F1: Represents an award of restricted stock units ("RSUs"). The RSUs will vest on the earlier of the date of the annual meeting of stockholders to be held in 2027 or June 26, 2027. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of restricted stock units ("RSUs"). The RSUs will vest on the earlier of the date of the annual meeting of stockholders to be held in 2027 or June 26, 2027. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Inspire Medical Systems, Inc.
Report date February 13, 2026 · Filed February 18, 2026
Section 16 reporting ended · disclosed 2026-02-18. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 43,988 |
Reported balance
After 2026-02-13 transaction · row 1
1 source rowRow 1 · 2026-02-13 · Tax withholding · Disposed 579 · Balance 43,988 F1: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a restricted stock unit award. |
| Common StockSEC Table I · non-derivative | IndirectBy Son | 1,475 |
Reported balance
Holding disclosure · report date 2026-02-13 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,475 |
| Common StockSEC Table I · non-derivative | IndirectBy Son | 1,475 |
Reported balance
Holding disclosure · report date 2026-02-13 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 1,475 |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a restricted stock unit award.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 18, 2022 Filed Apr 5, 2022 23:41 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftCommon Stock | 125 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-042917 · tm2211772-1_4seq1.xml · nonDerivative · entry 5 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Son Disclosed balance after: 1,125 Read SEC document |
| February 18, 2022 Filed Apr 5, 2022 23:41 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftCommon Stock | 250 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-042917 · tm2211772-1_4seq1.xml · nonDerivative · entry 4 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,176 Read SEC document |
| February 17, 2022 Filed Apr 5, 2022 23:41 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftCommon Stock | 125 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-042917 · tm2211772-1_4seq1.xml · nonDerivative · entry 3 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Son Disclosed balance after: 1,125 Read SEC document |
| February 17, 2022 Filed Apr 5, 2022 23:41 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftCommon Stock | 125 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-042917 · tm2211772-1_4seq1.xml · nonDerivative · entry 2 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Daughter Disclosed balance after: 1,125 Read SEC document |
| February 17, 2022 Filed Apr 5, 2022 23:41 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftCommon Stock | 250 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-042917 · tm2211772-1_4seq1.xml · nonDerivative · entry 1 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,426 F1 · balance_after: Includes 52 shares acquired under the Inspire Medical Systems, Inc. (the "Company") 2018 Employee Stock Purchase Plan on December 31, 2021. Read SEC document |
| February 11, 2022 Filed Feb 15, 2022 21:34 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantEmployee Stock Option (Right to Buy) · Derivative | 5,924 | $0.00 Strike: $227.53 | $0.00 |
DisclosureSEC source: 0001104659-22-023829 · tm226817-6_4seq1.xml · derivative · entry 1 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,924 Underlying: Common Stock · 5,924 shares Expires 2032-02-11 F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of Feruary 11, 2022 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| September 28, 2021 Filed Sep 30, 2021 20:23 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 329 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001104659-21-121240 · tm2128930-1_4seq1.xml · derivative · entry 6 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 329 shares Expires 2027-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| September 28, 2021 Filed Sep 30, 2021 20:23 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,819 | $0.00 Strike: $10.38 | $0.00 |
DisclosureSEC source: 0001104659-21-121240 · tm2128930-1_4seq1.xml · derivative · entry 5 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,290 Underlying: Common Stock · 2,819 shares Expires 2028-04-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested and became exercisable as to 25% of the original 22,556 underlying shares on April 9, 2019 and has vested or will vest and become exercisable with respect to the remaining 75% of the original underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| September 28, 2021 Filed Sep 30, 2021 20:23 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,607 | $0.00 Strike: $42.15 | $0.00 |
DisclosureSEC source: 0001104659-21-121240 · tm2128930-1_4seq1.xml · derivative · entry 4 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,852 Underlying: Common Stock · 1,607 shares Expires 2028-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested and became exercisable as to 25% of the original 25,000 underlying shares on December 18, 2019 and has vested or will vest and become exercisable with respect to the remaining 75% of the original underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| September 28, 2021 Filed Sep 30, 2021 20:23 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 329 | $0.94 | $309.26 |
DisclosureSEC source: 0001104659-21-121240 · tm2128930-1_4seq1.xml · nonDerivative · entry 3 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,624 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 28, 2021 Filed Sep 30, 2021 20:23 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 2,819 | $10.38 | $29,261.22 |
DisclosureSEC source: 0001104659-21-121240 · tm2128930-1_4seq1.xml · nonDerivative · entry 2 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,295 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 28, 2021 Filed Sep 30, 2021 20:23 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 1,607 | $42.15 | $67,735.05 |
DisclosureSEC source: 0001104659-21-121240 · tm2128930-1_4seq1.xml · nonDerivative · entry 1 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,476 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 80 shares acquired under the Company's 2018 Employee Stock Purchase Plan since the date of the reporting person's last ownership report. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 20:11 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,645 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001104659-21-037120 · tm219802-1_4seq1.xml · derivative · entry 15 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 329 Underlying: Common Stock · 1,645 shares Expires 2027-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vested and became exercisable as to 25% of the original 15,789 underlying shares on April 1, 2018 and has vested or will vest and become exercisable with respect to the remaining 75%of the original underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. F6 · balance_after: Prior Form 4s dated July 23, 2020 and October 13, 2020 previously misstated the number of remaining shares underlying this option award and such number has been corrected in this Form 4. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 20:11 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 376 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001104659-21-037120 · tm219802-1_4seq1.xml · derivative · entry 14 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 376 shares Expires 2027-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 20:11 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,350 | $0.00 Strike: $10.38 | $0.00 |
DisclosureSEC source: 0001104659-21-037120 · tm219802-1_4seq1.xml · derivative · entry 13 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,109 Underlying: Common Stock · 2,350 shares Expires 2028-04-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested and became exercisable as to 25% of the original 22,556 underlying shares on April 9, 2019 and has vested or will vest and become exercisable with respect to the remaining 75% of the original underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 20:11 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,095 | $0.00 Strike: $42.15 | $0.00 |
DisclosureSEC source: 0001104659-21-037120 · tm219802-1_4seq1.xml · derivative · entry 12 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,459 Underlying: Common Stock · 6,095 shares Expires 2028-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested and became exercisable as to 25% of the original 25,000 underlying shares on December 18, 2019 and has vested or will vest and become exercisable with respect to the remaining 75% of the original underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 20:11 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,034 | $0.00 Strike: $71.00 | $0.00 |
DisclosureSEC source: 0001104659-21-037120 · tm219802-1_4seq1.xml · derivative · entry 11 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,966 Underlying: Common Stock · 2,034 shares Expires 2029-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested and became exercisable as to 25% of the original 20,000 underlying shares on December 16, 2020 and has vested or will vest and become exercisable with respect to the remaining 75% of the original underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 20:11 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 1,645 | $0.94 | $1,546.30 |
DisclosureSEC source: 0001104659-21-037120 · tm219802-1_4seq1.xml · nonDerivative · entry 10 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,789 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 20:11 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 376 | $0.94 | $353.44 |
DisclosureSEC source: 0001104659-21-037120 · tm219802-1_4seq1.xml · nonDerivative · entry 9 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,144 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 20:11 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 2,350 | $10.38 | $24,393.00 |
DisclosureSEC source: 0001104659-21-037120 · tm219802-1_4seq1.xml · nonDerivative · entry 8 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,768 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 20:11 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 6,095 | $42.15 | $256,904.25 |
DisclosureSEC source: 0001104659-21-037120 · tm219802-1_4seq1.xml · nonDerivative · entry 7 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,418 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 20:11 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 2,034 | $71.00 | $144,414.00 |
DisclosureSEC source: 0001104659-21-037120 · tm219802-1_4seq1.xml · nonDerivative · entry 6 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,323 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 22:39 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 400 | $228.30 | $91,318.00 |
DisclosureSEC source: 0001104659-21-030172 · tm218265-1_4seq1.xml · nonDerivative · entry 6 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,769 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $228.18 to $228.49. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 22:39 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 1,000 | $227.44 | $227,440.00 |
DisclosureSEC source: 0001104659-21-030172 · tm218265-1_4seq1.xml · nonDerivative · entry 5 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,169 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $227.18 to $228.00. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 22:39 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 4,401 | $226.68 | $997,618.68 |
DisclosureSEC source: 0001104659-21-030172 · tm218265-1_4seq1.xml · nonDerivative · entry 4 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,169 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $226.16 to $227.13. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 22:39 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 7,817 | $225.74 | $1,764,609.58 |
DisclosureSEC source: 0001104659-21-030172 · tm218265-1_4seq1.xml · nonDerivative · entry 3 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,570 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $225.14 to $226.12. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 22:39 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 5,682 | $224.78 | $1,277,199.96 |
DisclosureSEC source: 0001104659-21-030172 · tm218265-1_4seq1.xml · nonDerivative · entry 2 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,387 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $224.14 to $225.11. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 22:39 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 700 | $223.74 | $156,618.00 |
DisclosureSEC source: 0001104659-21-030172 · tm218265-1_4seq1.xml · nonDerivative · entry 1 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,069 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $223.13 to $224.10. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes 118 shares acquired under the Company's 2018 Employee Stock Purchase Plan since the date of the reporting person's last ownership report. Read SEC document |
| January 21, 2021 Filed Mar 16, 2021 20:11 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftCommon Stock | 120 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-037120 · tm219802-1_4seq1.xml · nonDerivative · entry 5 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Son Disclosed balance after: 1,000 Read SEC document |
| January 21, 2021 Filed Mar 16, 2021 20:11 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftCommon Stock | 120 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-037120 · tm219802-1_4seq1.xml · nonDerivative · entry 4 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Son Disclosed balance after: 1,000 Read SEC document |
| January 21, 2021 Filed Mar 16, 2021 20:11 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftCommon Stock | 120 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-037120 · tm219802-1_4seq1.xml · nonDerivative · entry 3 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Son Disclosed balance after: 1,000 Read SEC document |
| January 21, 2021 Filed Mar 16, 2021 20:11 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftCommon Stock | 120 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-037120 · tm219802-1_4seq1.xml · nonDerivative · entry 2 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Daughter Disclosed balance after: 1,000 Read SEC document |
| January 21, 2021 Filed Mar 16, 2021 20:11 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftCommon Stock | 480 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-037120 · tm219802-1_4seq1.xml · nonDerivative · entry 1 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,289 Read SEC document |
| December 15, 2020 Filed Dec 16, 2020 22:50 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 1,853 | $191.76 | $355,331.28 |
DisclosureSEC source: 0001104659-20-136411 · a4.xml · nonDerivative · entry 5 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,651 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $191.11 to $192.05. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 15, 2020 Filed Dec 16, 2020 22:50 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 200 | $190.53 | $38,106.00 |
DisclosureSEC source: 0001104659-20-136411 · a4.xml · nonDerivative · entry 4 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,504 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| December 15, 2020 Filed Dec 16, 2020 22:50 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 47 | $189.36 | $8,899.92 |
DisclosureSEC source: 0001104659-20-136411 · a4.xml · nonDerivative · entry 3 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,704 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.11 to $189.49. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 15, 2020 Filed Dec 16, 2020 22:50 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 800 | $188.44 | $150,752.00 |
DisclosureSEC source: 0001104659-20-136411 · a4.xml · nonDerivative · entry 2 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,751 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.01 to $188.90. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 15, 2020 Filed Dec 16, 2020 22:50 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 100 | $185.00 | $18,500.00 |
DisclosureSEC source: 0001104659-20-136411 · a4.xml · nonDerivative · entry 1 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,551 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 22:50 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantEmployee Stock Option (Right to Buy) · Derivative | 17,300 | $0.00 Strike: $194.82 | $0.00 |
DisclosureSEC source: 0001104659-20-136411 · a4.xml · derivative · entry 10 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,300 Underlying: Common Stock · 17,300 shares Expires 2030-12-14 F5 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of December 14, 2020 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| November 17, 2020 Filed Nov 19, 2020 21:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 331 | $173.45 | $57,411.95 |
DisclosureSEC source: 0001104659-20-127353 · a4.xml · nonDerivative · entry 5 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,651 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $173.18 to $173.95. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 17, 2020 Filed Nov 19, 2020 21:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 1,929 | $172.19 | $332,154.51 |
DisclosureSEC source: 0001104659-20-127353 · a4.xml · nonDerivative · entry 4 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,982 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $171.96 to $172.94. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 17, 2020 Filed Nov 19, 2020 21:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 340 | $170.46 | $57,956.40 |
DisclosureSEC source: 0001104659-20-127353 · a4.xml · nonDerivative · entry 3 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,911 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $170.42 to $170.75. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 17, 2020 Filed Nov 19, 2020 21:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 300 | $169.09 | $50,727.00 |
DisclosureSEC source: 0001104659-20-127353 · a4.xml · nonDerivative · entry 2 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,251 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $168.9 to $169.46. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 17, 2020 Filed Nov 19, 2020 21:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 100 | $167.36 | $16,736.00 |
DisclosureSEC source: 0001104659-20-127353 · a4.xml · nonDerivative · entry 1 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,551 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| October 20, 2020 Filed Oct 22, 2020 20:19 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 700 | $121.12 | $84,784.00 |
DisclosureSEC source: 0001104659-20-117158 · a4.xml · nonDerivative · entry 3 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,651 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.71 to $121.49. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 20, 2020 Filed Oct 22, 2020 20:19 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 600 | $122.11 | $73,266.00 |
DisclosureSEC source: 0001104659-20-117158 · a4.xml · nonDerivative · entry 2 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,351 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.75 to $122.55. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 20, 2020 Filed Oct 22, 2020 20:19 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 1,700 | $123.80 | $210,460.00 |
DisclosureSEC source: 0001104659-20-117158 · a4.xml · nonDerivative · entry 1 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,951 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.08 to $123.98. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 12:00 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,494 | $0.00 Strike: $42.15 | $0.00 |
DisclosureSEC source: 0001104659-20-114217 · a4.xml · derivative · entry 12 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,554 Underlying: Common Stock · 5,494 shares Expires 2028-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested and became exercisable as to 25% of the original 25,000 underlying shares on December 18, 2019 and has vested or will vest and become exercisable with respect to the remaining 75% of the original underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 12:00 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,410 | $0.00 Strike: $10.38 | $0.00 |
DisclosureSEC source: 0001104659-20-114217 · a4.xml · derivative · entry 11 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,459 Underlying: Common Stock · 1,410 shares Expires 2028-04-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested and became exercisable as to 25% of the original 22,556 underlying shares on April 9, 2019 and has vested or will vest and become exercisable with respect to the remaining 75% of the original underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 12:00 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 987 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001104659-20-114217 · a4.xml · derivative · entry 10 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,228 Underlying: Common Stock · 987 shares Expires 2027-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested and became exercisable as to 25% of the original 15,789 underlying shares on April 1, 2018 and has vested or will vest and become exercisable with respect to the remaining 75% of the original underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.